Clinical trial
A Prospective, Multi-center, Single-arm Clinical Investigation for Evaluation of the Safety and Effectiveness of the MicroPort™ CardioFlow VitaFlow™ Transcatheter Aortic Valve System in the Treatment of Severe Aortic Stenosis
NCT04655742 is registered in ClinicalTrials.gov with Shanghai MicroPort CardioFlow Medtech Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multi-center, Single-arm Clinical Investigation for Evaluation of the Safety and Effectiveness of the MicroPort™ CardioFlow VitaFlow™ Transcatheter Aortic Valve System in the Treatment of Severe Aortic Stenosis
- Lead sponsor
- Shanghai MicroPort CardioFlow Medtech Co., Ltd.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 27, 2014
- Completion date
- December 31, 2021
- Enrollment
- 120 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.